1. UBS Lux Equity Fund Biotech USD
UBS Lux Equity Fund Biotech USD P-acc
Fee
2.25%
ISIN
LU0069152568
Holdings
5
PriorNilsson Realinvest A
Fee
1.60%
ISIN
SE0005189537
Holdings
26
We have information about 7 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66). In comparison with PriorNilsson Realinvest, we have 25 holdings where Castellum is the largest holding (9.31), followed by John Mattson (9.3) and SCA (9.13).
Here we compare the holdings in UBS Lux Equity Fund Biotech USD and PriorNilsson Realinvest.
| UBS Lux Equity Fund Biotech USD | PriorNilsson Realinvest |
|---|---|
|
10.04 % |
 9.31 % |
|
9.21 % |
9.3 % |
 4.66 % |
9.13 % |
|
4.13 % |
5.63 % |
|
3.75 % |
4.75 % |
| - |
4.38 % |
| - |
4.1 % |
| - |
3.85 % |
| - |
3.47 % |
| - |
3.17 % |
| - |
 3.15 % |
| - |
3.04 % |
| - |
2.94 % |
| - |
 2.83 % |
| - |
2.6 % |
| - |
2.36 % |
| - |
2.2 % |
| - |
2.11 % |
| - |
1.92 % |
| - |
1.92 % |
| - |
1.79 % |
| - |
1.75 % |
| - |
 1.66 % |
| - |
1.46 % |
| - |
1.13 % |
| - |
0.99 % |
The list of fund holdings was last updated on September 10, 2025.
